The store will not work correctly when cookies are disabled.
3-amino-4-(furan-2-yl)-6,7,8,9-tetrahydro-5H-cyclohepta[e]thieno[2,3-b]pyridine-2-carboxamide
ID: ALA1093963
PubChem CID: 5073419
Max Phase: Preclinical
Molecular Formula: C17H17N3O2S
Molecular Weight: 327.41
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: NC(=O)c1sc2nc3c(c(-c4ccco4)c2c1N)CCCCC3
Standard InChI: InChI=1S/C17H17N3O2S/c18-14-13-12(11-7-4-8-22-11)9-5-2-1-3-6-10(9)20-17(13)23-15(14)16(19)21/h4,7-8H,1-3,5-6,18H2,(H2,19,21)
Standard InChI Key: CHYAJKOQMTYFLM-UHFFFAOYSA-N
Molfile:
RDKit 2D
23 26 0 0 0 0 0 0 0 0999 V2000
16.5235 -10.5546 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.5257 -8.9090 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.2368 -9.3180 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.2343 -10.1470 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.0219 -10.4056 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
18.5113 -9.7364 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.0261 -9.0644 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.2825 -8.2833 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.3334 -9.7389 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.7423 -10.4521 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
19.7466 -9.0282 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.5252 -8.0869 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.1849 -7.6034 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.9304 -6.8216 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.1082 -6.8221 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.8547 -7.6042 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
15.8167 -9.3192 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.8133 -10.1416 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.1655 -10.6575 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.1700 -8.8017 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.3606 -10.4765 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.3631 -8.9855 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.0057 -9.7316 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9 11 1 0
3 2 2 0
2 12 1 0
12 13 2 0
2 17 1 0
4 5 1 0
5 6 1 0
6 7 2 0
13 14 1 0
14 15 2 0
15 16 1 0
16 12 1 0
7 3 1 0
3 4 1 0
17 18 2 0
7 8 1 0
18 19 1 0
18 1 1 0
17 20 1 0
6 9 1 0
19 21 1 0
1 4 2 0
20 22 1 0
9 10 2 0
21 23 1 0
22 23 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 327.41 | Molecular Weight (Monoisotopic): 327.1041 | AlogP: 3.51 | #Rotatable Bonds: 2 |
Polar Surface Area: 95.14 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: 3.28 | CX LogD: 3.28 |
Aromatic Rings: 3 | Heavy Atoms: 23 | QED Weighted: 0.70 | Np Likeness Score: -1.66 |
References
1. Lockman JW, Reeder MD, Suzuki K, Ostanin K, Hoff R, Bhoite L, Austin H, Baichwal V, Adam Willardsen J.. (2010) Inhibition of eEF2-K by thieno[2,3-b]pyridine analogues., 20 (7): [PMID:20189382] [10.1016/j.bmcl.2010.02.005] |